Cargando…
Enhanced radiation-induced immunogenic cell death activates chimeric antigen receptor T cells by targeting CD39 against glioblastoma
Chimeric antigen receptor (CAR)-T cells directed to solid tumors have been less effective, due in part to the low or lost expression of specific tumor antigens. Herein, we developed a different strategy to enhance CAR-T cell persistence and efficacy by producing a multispecific CAR-T or vaccine base...
Autores principales: | Sun, Ting, Li, Yanyan, Yang, Ying, Liu, Bin, Cao, Yufei, Yang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573869/ https://www.ncbi.nlm.nih.gov/pubmed/36245000 http://dx.doi.org/10.1038/s41419-022-05319-1 |
Ejemplares similares
-
Bip inhibition in glioma stem cells promotes radiation-induced immunogenic cell death
por: Yang, Wei, et al.
Publicado: (2020) -
Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation
por: Liu, Bin, et al.
Publicado: (2022) -
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma
por: Hänsch, Lena, et al.
Publicado: (2023) -
Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
por: Zhang, Peng, et al.
Publicado: (2022) -
Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
por: Li, Long, et al.
Publicado: (2020)